subject: Aarkstore Enterprise---aerocrine Ab (aero B) - Financial And Strategic Analysis Review [print this page] Aerocrine AB (Aerocrine) is a medical technology company, engaged in the development and manufacturing of products and services pertaining to asthma management and care. The company markets its flagship products under the brand name of Niox. It markets two products globally NIOX Flex and NIOX MINO. Aerocrines quality management system complies with ISO-13485 certification. All products and services provided by Aerocrine function according to required specifications, with sufficient safety and satisfaction for the patient, physician, personnel or any other intended user, in compliance with applicable authority requirements.
Aerocrine AB Key Recent Developments
Apr 07, 2010 Aerocrine Updates On Legal Action Against Apieron
Apr 07, 2010 Aerocrine Updates On Legal Action Against Apieron
Jan 13, 2010 US Expert Panel Recommends FENO In Asthma
Jul 16, 2009 Apieron Files Patent Infringement Lawsuit Against Aerocrine
This comprehensive SWOT profile of Aerocrine AB provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including,
- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
